Filing Details
- Accession Number:
- 0001213900-24-030037
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-03 21:30:11
- Reporting Period:
- 2024-04-01
- Accepted Time:
- 2024-04-03 21:30:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1769804 | Augmedix Inc. | AUGX | Services-Business Services, Nec (7389) | 833299164 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1826129 | Ian Shakil | C/O Augmedix, Inc. 111 Sutter Street, Suite 1300 San Francisco CA 94104 | Chief Strategy Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-04-01 | 51,346 | $0.64 | 239,012 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-04-01 | 51,346 | $3.89 | 187,666 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-01 | 7,632 | $4.02 | 180,034 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-02 | 38,463 | $3.89 | 141,571 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-04-01 | 51,346 | $0.00 | 51,346 | $0.64 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 42,919 | 2030-06-03 | No | 4 | M | Direct |
Footnotes
- This transaction was executed pursuant to a Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades ranging from $3.8000 to $3.9900. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $3.9900 to $4.1100. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- Fully vested.
Billionaire Hedge Funds
